Brian Henick, MD, discussed plans to investigate agents targeting ULBP2/5/6, antibody-drug conjugates, and other novel therapies in lung cancer research.
Brian Henick, MD
Advertisement
Articles by Brian Henick, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Delays Decision on Subcutaneous Isatuximab in Multiple Myeloma
2
Adult T-Cell Leukemia/Lymphoma and Epstein-Barr Virus–Positive DLBCL: A Rare Concomitant Association
3
The Synergy of Early Detection and KRAS Inhibition in Pancreatic Cancer
4
European Commission Approves Tovorafenib in BRAF+ Pediatric Low-Grade Glioma
5